NBEA | Neurobeachin | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NECAB2 | N-terminal EF-hand calcium binding protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NEFM | Neurofilament, medium polypeptide | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NGB | Neuroglobin | Predicted intracellular proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000437563} | Predicted membrane proteins
| | | | | Tissue enhanced |
NLGN2 | Neuroligin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NOVA2 | Neuro-oncological ventral antigen 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | | | | Tissue enhanced |
NTM | Neurotrimin | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PCSK1N | Proprotein convertase subtilisin/kexin type 1 inhibitor | Predicted secreted proteins
| | | | | Tissue enhanced |
PLXNB3 | Plexin B3 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PNMAL1 | Paraneoplastic Ma antigen family-like 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA3 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRN2 | Protein tyrosine phosphatase, receptor type, N polypeptide 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PTPRR | Protein tyrosine phosphatase, receptor type, R | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RNF112 | Ring finger protein 112 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RNFT2 | Ring finger protein, transmembrane 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
RTBDN | Retbindin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SAMD14 | Sterile alpha motif domain containing 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCG5 | Secretogranin V (7B2 protein) | Predicted secreted proteins
| | | | | Tissue enhanced |
SEPT4 | Septin 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC6A11 | Solute carrier family 6 (neurotransmitter transporter), member 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
SPTBN2 | Spectrin, beta, non-erythrocytic 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SRGAP3 | SLIT-ROBO Rho GTPase activating protein 3 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
SYT2 | Synaptotagmin II | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
SYT7 | Synaptotagmin VII | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SYT9 | Synaptotagmin IX | Predicted membrane proteins
| | | | | Tissue enhanced |
TCEAL7 | Transcription elongation factor A (SII)-like 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TMEM132E | Transmembrane protein 132E | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM169 | Transmembrane protein 169 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TNFSF18 | Tumor necrosis factor (ligand) superfamily, member 18 | Predicted membrane proteins
| | | | | Tissue enhanced |
TSPAN7 | Tetraspanin 7 | CD markers Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TTBK1 | Tau tubulin kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
WASF1 | WAS protein family, member 1 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ZIC1 | Zic family member 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |